Resultados de la búsqueda 81-90 of 1983 for Cold, common

  1. Cirugía - Ensayos clínicos - Mayo Clinic

    The objective of this study is to evaluate the image quality and radiation dose of a CT angiography protocol (CTA) using tube potential selection and weight- ...

  2. Ensayos clínicos - Centro Pediátrico de Mayo Clinic

    The investigators have chosen this population because 1) These mutations are the most common genetic causes of LQTS, and 2) Offspring will have high risk of ...

  3. Herpes labiales - Mayo Clinic

    Herpes labiales. June 29, 2023. Original article: https://www.mayoclinic.org/es/diseases-conditions/cold-sore/multimedia/cold-sore-/img-20005981 . Mayo ...

  4. Manos frías Causas - Mayo Clinic

    Causes of cold hands include: Anemia · Enfermedad de Buerger · Diabetes · Congelación · Lupus · Enfermedad de Raynaud · Esclerodermia. Las causas que aquí se ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Colorectal cancer is the third most commonly diagnosed cancer in both men ... Hyperplastic polyps are common but they have a low malignancy potential (3).

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Colorectal cancer is the third most commonly diagnosed cancer in both men ... Hyperplastic polyps are common but they have a low malignancy potential (3).

  7. Cirugía - Ensayos clínicos - Mayo Clinic

    The objective of this trial is to evaluate the effectiveness of left atrial appendage exclusion (LAAE) for the prevention of ischemic stroke or systemic ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Colorectal cancer is the third most commonly diagnosed cancer in both men ... Hyperplastic polyps are common but they have a low malignancy potential (3).

  9. Ensayos clínicos - Centro Pediátrico de Mayo Clinic

    The investigators have chosen this population because 1) These mutations are the most common genetic causes of LQTS, and 2) Offspring will have high risk of ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute ...